April 18, 2008 (Chicago, Illinois) — A new study finds that the use of drugs with anticholinergic activity is associated with a more rapid decline in cognitive performance in older individuals. The ...

A class of drug commonly used to treat everything from chronic obstructive pulmonary disease (COPD) to depression has now been linked to accelerating the loss of mobility in older age. This adds a new ...

The share of patients meeting the definition of polypharmacy for the condition of overactive bladder declined from 2006 to 2017, but the phenomenon was still prevalent in women and patients in nursing ...

In middle-aged and older adults, anticholinergic drug burden is associated with an increased risk for cardiovascular events.

There are a number of things that can increase the risk of dementia: age, of course, as well as certain genetic profiles and behaviors such as smoking and drinking. Some of the same things that ...

Anticholinergic burden refers to the cumulative effect of taking one or more medications with anticholinergic properties, which inhibit the neurotransmitter acetylcholine. In older adults, an ...

Scientists have long found a possible link between anticholinergic drugs and an increased risk of dementia. A study published in the journal JAMA Internal Medicine on Monday suggests that the link is ...

A new study has found that widely used prescription drugs are linked to “nearly a 50% increased odds of dementia” in older adults, researchers say. The authors of the report, which appears in JAMA ...

Falls, confusion, cognitive decline, dry mouth, constipation and urinary retention. In a new NPS MedicineWise podcast episode released today, Dr Kate Annear, NPS MedicineWise medical adviser and GP ...

The use of some common drugs has been associated with decreased brain size. Anticholinergics that are responsible for transferring electrical impulses between nerves have been found to lower ...

A link between anticholinergic drug use and cognitive impairment was recently observed from observational studies on randomized clinical trials. Regenstrief Institute research scientists examined ...